
Meto HT 25mg/12.5mg Tablet ER
Marketer
Mano Pharma Pvt Ltd
Salt Composition
Metoprolol Succinate (25mg) + Hydrochlorothiazide (12.5mg)
Overview Meto HT 25mg/12.5mg Tablet ER
Cardiovascular support with Meto HT 25mg/12.5mg Extended-Release tablets is indicated for managing hypertension. This combination therapy is employed when monotherapy proves insufficient. It contributes to a reduced risk of stroke and myocardial infarction. Prompt initiation improves post-heart attack survival rates. Administer Meto HT 25mg/12.5mg ER tablets once daily, preferably in the morning, with or without food, to minimize nocturia. Continuous use, as directed by your physician, is crucial, even with asymptomatic hypertension, as discontinuation can exacerbate the condition. Lifestyle modifications, such as regular physical activity, weight management, and a balanced diet, complement this treatment. Strict adherence to your doctor's instructions is vital. Commonly reported adverse effects include gastrointestinal upset (nausea, constipation, diarrhea) and fatigue. Report persistent, worsening, or intolerable side effects to your doctor. Increased fluid intake may alleviate dryness and weakness. Postural hypotension (dizziness, headache) may necessitate gradual positional changes and driving precautions. Prior to commencing treatment, disclose any renal or hepatic impairment, pregnancy, breastfeeding, or concomitant medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, glucose, and electrolyte levels (potassium, magnesium) is recommended to assess therapeutic efficacy and safety.
Primary Ingredients of Meto HT 25mg/12.5mg Tablet ER
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Meto HT 25mg/12.5mg Tablet ER
Elevated blood pressure
Major Benefits of Meto HT 25mg/12.5mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meto HT 25mg/12.5mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Meto HT 25mg/12.5mg Tablet ER:
- Fatigue
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Meto HT 25mg/12.5mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the Meto HT 25mg/12.5mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent daily timing is recommended.
How Meto HT 25mg/12.5mg Tablet ER works:
Metoprolol Succinate/Hydrochlorothiazide 25mg/12.5mg Extended-Release tablets (brand name: Meto HT) combine two agents to control hypertension. Metoprolol Succinate, a beta-adrenergic blocking agent, decreases heart rate and enhances cardiac efficiency, improving blood circulation. Hydrochlorothiazide, a diuretic, reduces blood pressure by eliminating excess fluid and electrolytes, concurrently promoting vasodilation and better blood flow.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Meto HT 25mg/12.5mg extended-release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Meto HT 25mg/12.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Meto HT 25mg/12.5mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release Meto HT 25mg/12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneyCAUTION
Exercise caution when prescribing Meto HT 25mg/12.5mg Extended-Release tablets to individuals with severe renal impairment; dosage modification may be necessary. Physician consultation is advised. Meto HT 25mg/12.5mg Extended-Release tablets are generally unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Meto HT 25mg/12.5mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Meto HT 25mg/12.5mg Tablet ER :
For Meto HT 25mg/12.5mg Extended-Release Tablets, take a missed dose promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Meto HT 25mg/12.5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
